Results

Total Results: 635 records

Showing results for "topical treatment".

81. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/YALMYpRCoRSu9nhPFGudEm
    November 01, 2022 - helpful, and repeat serologic testing may be indicated.4 In symptomatic pregnant persons, antiviral therapy … Sexually transmitted infections treatment guidelines, 2021: genital herpes. … Accessed December 19, 2022. https://www.cdc.gov/std/treatment-guidelines/ herpes.htm 4. … Sexually transmitted infections treatment guidelines, 2021. … Accessed December 19, 2022. https://www.cdc.gov/std/ treatment/SexualHistory.htm 16.

82. USPSTF Clinician Summary of USPSTF Recommendation: Screening For Anxiety Disorders in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4RNVtFNUtF85_ErBy9cqC9
    June 01, 2023 - • Treatment for anxiety disorders in adults can include psychotherapy or pharmacotherapy. … consider the unique balance of benefits and harms in the perinatal period when deciding the best treatment … Anxiety disorders are often unrecognized in primary care settings and substantial delays in treatment

83. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
    October 15, 2007 - of drug therapy and adverse quality-of-life outcomes. … New evidence on the harms of treatment of early hypertension shows that pharmacologic therapy is associated … continue to outweigh the harms, the USPSTF included new information on the adverse effects of drug therapy … of drug therapy, and quality-of-life outcomes. … New evidence on the harms of treatment of early hypertension shows that pharmacologic therapy is associated

84. 14th Annual Report to Congress: High-Priority Evidence Gaps Across the Lifespan, in All Communities (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
    January 01, 2024 - • The potential harms of screening and treatment such as labeling, stigma, parent anxiety, other … • How variations in care (including diagnosis and treatment) lead to increased risk of breast cancer … • Research is needed to assess the benefits and harms of treatment (e.g., oral or intravenous iron) … – Research is needed to understand how variations in care (including diagnosis and treatment) lead … He practices family medicine and leads the medical obesity treatment program.

85. Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/oZSntFpszryu7mAnjdhkrw
    September 05, 2023 - Eleven RCTs (n = 1293) reported harms of anxiety treatments. … Does treatment (cognitive behavioral therapy or pharmacotherapy) of anxiety result in improved health … 2 Does treatment (cognitive behavioral therapy or pharmacotherapy) of anxiety result in improved health … 4 What are the harms of treatment (cognitive behavioral therapy or pharmacotherapy) in children and … US Department of Commerce. 2020 National Survey of Children’s Health: Topical Frequencies.

86. Archived: Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
    September 25, 2014 - ‡ Other treatments or combinations Comparisons KQs 1, 4: Screened vs. nonscreened … studies comparing treatment with placebo, no treatment, or another eligible treatment KQs 1, 3 … –5: No comparison; nonconcordant historical controls; comparisons with screening tests or treatments … 9 months, isoniazid twice weekly by directly observed therapy for 6 or 9 months, rifampin daily for … 4 months, or isoniazid plus rifapentine weekly by directly observed therapy for 3 months.

87. Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
    December 01, 2007 - of drug therapy and adverse quality-of-life outcomes. … New evidence on the harms of treatment of early hypertension shows that pharmacologic therapy is associated … continue to outweigh the harms, the USPSTF included new information on the adverse effects of drug therapy … group allocation, reports of adverse effects of drug therapy, and quality-of-life out- comes. … New evidence on the harms of treatment of early hypertension shows that phar- macologic therapy is associated

88. Archived: Final Research Plan: Screening for Depression in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan44/depression-in-adults-screening
    July 03, 2014 - How is treatment managed in patients who screen positive for depression (e.g., how likely is it that … is the patient to receive a full therapeutic dose of treatment)? … What is the acceptability of depression treatment to patients and providers? … Is treatment (psychotherapy or pharmacologic) effective for relatively mild depression? … processes, such as treatment initiation, referral for treatment, referral acceptance, and compliance

89. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
    August 01, 2022 - Treatment Several antibiotics are available for the treatment of LTBI. … isoniazid monotherapy, CDC-recommended regimens can be self-administered, including once-weekly combination therapy … Targeted tuberculin testing and treatment of latent tuberculosis infection. … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

90. Screening for Latent Tuberculosis Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
    September 06, 2016 - Treatment Recommendations for the treatment of LTBI are available from the CDC.17 Additional Approaches … group or rifapentine plus isoniazid with isoniazid alone and found that the combination therapy was noninferior … Treatment regimens for latent TB infection (LTBI). http://www.cdc.gov/tb/topic/treatment/ltbi.htm. 2016 … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

91. Behavioral Counseling Interventions: An Evidence-based Approach | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-interventions-evidence-based-approach
    March 04, 2021 - adapting existing USPSTF methods to issues and challenges raised by behavioral counseling intervention topical … Interventions to help patients change unhealthy behaviors, like treatments for patients with chronic … Further, "counseling" is a broadly used but imprecise term that covers a wide array of preventive and therapeutic … activities, from mental health or marital therapy to the provision of health education and behavior … The future of smoking cessation therapy in the United States.  Addiction  1996;91(12):1797-1802.

92. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/use-decision-models-development-evidence-based-clinical-preventive-services-recommendations
    May 01, 2019 - directly in clinical trials, but there is evidence that HIV can be diagnosed accurately and that early treatment … Does treatment reduce the incidence of the intermediate outcome?     a. … Does treatment work under ideal clinical trial conditions?     b. … How do the efficacy and effectiveness of treatments compare in community settings? 5. … Does treatment improve health outcomes for people diagnosed clinically?     a.

93. Procedure Manual Appendix XV. Specialist Expert Reviewer Nomination and Selection | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-xv-specialist-expert-reviewer-nomination-and-selection
    October 01, 2017 - national level (i.e., not a state or community level) Issue preventive guidelines (i.e., not treatment … and skills in evidence-based medicine Content expertise in prevention, screening, diagnosis, and treatment

94. 10th Annual Report to Congress on High-Priority Evidence Gaps (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
    November 01, 2020 - Evaluate screening for major depressive disorder in children age 11 years or younger • Evaluate combined treatments … might be effective in individuals at average or high risk, so we can understand whether tailored therapies … studies that: – Are larger and have more children as participants – Examine longer-term effects of treatment … depressive disorder in children age 11 years or younger • Evaluate the benefits and harms of combined treatments … individuals, such as American Indians and Hispanic/Latino adolescents, so we can determine whether tailored therapies

95. Screening for iron deficiency anemia in young children literature surveillance report 2023 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sCkggReHbVWXtLoqWhEPrh
    July 01, 2023 - identified important gaps and recommends further research on: • The effect of routine screening for or treatment … assessment tools to identify children who are at increased risk for IDA; • The harms of screening for or treatment … We identified one study focused on screening and treatment for IDA in Canadian children.1 Children ( … In a sub-study, 130 of these children aged 12 to 40 months were enrolled in 4 months of treatment based

96. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/decision-modeling-for-uspstf_0.pdf
    July 01, 2016 - Does treatment reduce the incidence of the intermediate outcome? a. … Does treatment work under ideal clinical trial conditions? b. … How do the efficacy and effectiveness of treatments compare in community settings? 5. … Does treatment improve health outcomes for people diagnosed clinically? a. … Does treatment result in adverse effects?

97. Frequently Asked Questions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/faqs/final-faq-document/breast-cancer-screening
    April 30, 2024 - Specifically, we need to know how best to address health disparities across screening and treatment experienced … very high risk of breast cancer due to certain genetic markers or a history of high-dose radiation therapy … s important that patients receive equitable and appropriate follow-up after screening and effective treatment … year increases the number of harms, like being told you might have cancer when you don’t, or receiving treatment … Importantly, we need to know how best to address the health disparities across screening and treatment

98. Screening for Visual Impairment in Children Younger than Age 5 Years: An Update of the Evidence from Randomized Controlled Trials, 1999–2003 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkowkNFvCYh9hMnEBcCkGh
    May 01, 2004 - lead to better treatment outcomes (primary prevention)? … Both treatments were well-tolerated. … atropine or other intereye acuity cycloplegics; more difference ≥ 3 LogMAR than 2 mos of lines amblyopia therapy … patients (9%), respectively (P < 0.001); this difference did not persist with further follow- up; both treatments … for Most children in treatment show The Amblyopia Treatment Study, a good-quality head- amblyopia effective

99. Summary of USPSTF Draft Recommendation: Screening for Syphilis Infection in Pregnant Persons (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/LXxZgb3TCBzcEKd5eBbown
    December 23, 2024 - all pregnant people who screen positive receive timely, equitable, and evidence-based follow-up and treatment … Screening and treatment during pregnancy can help prevent babies from developing congenital syphilis … Screening and treatment also help keep the pregnant person healthy. What are the harms? … In addition, it is possible for the pregnant person to have an allergy or reaction to treatment.

100. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
     January 01, 2012 - Screening and Treatment for Depression in Children 3. … of diagnosis and treatment on quality of life. 4. … However, the USPSTF found a lack of relevant studies on whether drug therapies reduce the risk for fractures … D Hormone Replacement Therapy: Preventive Medication for Postmenopausal Women The USPSTF recommends … D Hormone Replacement Therapy: Preventive Medication for Postmenopausal Women Who Have Had a Hysterectomy